Daniel S. Levine

Daniel S. Levine is editor of Rare Daily. You can contact him by sending email to editor@globalgenes.org

Understanding Strength
By Jennifer The physician who came to see me happened to be a Persian Jew. After listening to my story and examining me, he diagnosed a… Continue Reading
FDA Accepts Shire’s Application for HAE Therapeutic, Grants Priority Review
Rare Daily Staff Shire said the U.S. Food and Drug Administration accepted its application and granted priority review to lanadelumab, an… Continue Reading
Finding a Rare Friend
Makayla Allison’s daughter Lily was born with a rare genetic disease with many symptoms, complex challenges, and no diagnosis. As she grew… Continue Reading
Rare Leader: Kristin Smedley, President of Curing Retinal Blindness Foundation
The Basics Name: Kristin Smedley Title: President Organization: Curing Retinal Blindness Foundation Disease focus: We fund research for CRB1… Continue Reading
New Zealand Rare Disease Group Says NZ Government Breaks Election Promise
Rare Daily Staff The New Zealand Organisation for Rare Disorders said the New Zealand Government is failing to honor its election promise to… Continue Reading
Improving Access to Genetic Testing
About a year ago, Rep. Eric Swalwell, D-California, along with 14 other members of Congress, sent a letter to then Department of Health and… Continue Reading
Minoryx Therapeutics Spins Off See-Tx Platform to Create Gain Therapeutics
Rare Daily Staff Minoryx Therapeutics said it has spun off its Site-directed Enzyme Enhancement Therapy (SEE-Tx) platform to form Gain… Continue Reading

Follow us on Twitter